Methamphetamine and Ecstasy-Induced Acute Reversible Cerebellar Neurotoxicity in a 3-Year-Old Child: A Case Report

Area of Science:

• Pediatric Neurology
• Toxicology
• Neuroscience

Background:

• Substance use disorders are increasingly prevalent in pediatric populations.
• Neurological complications associated with substance use in children are a growing concern.
• Acute neurotoxicity can manifest with diverse and severe symptoms in young individuals.

Purpose of the Study:

• To report the youngest known case of acute reversible cerebellar neurotoxicity induced by methamphetamine and ecstasy in a child.
• To highlight the potential for severe neurological impairment from recreational drug exposure in pediatric patients.
• To emphasize the importance of considering toxicological assessments in the differential diagnosis of acute neurological deficits in children.

Main Methods:

• Case presentation of a 3-year-old female with acute onset neurological symptoms.
• Comprehensive neurological examination including assessment of gait, speech, and reflexes.
• Diagnostic workup involving neuroimaging (MRI), cerebrospinal fluid analysis, and laboratory tests, including urine drug screening.

Main Results:

• The patient presented with dysarthria, truncal ataxia, hypotonia, and hyporeflexia.
• Standard neurological and laboratory investigations were unremarkable, except for positive urine tests for methamphetamine and ecstasy.
• Symptoms showed significant improvement during hospitalization, indicating an acute and reversible neurotoxic process.

Conclusions:

• This case represents the youngest documented instance of acute reversible cerebellar neurotoxicity linked to methamphetamine and ecstasy.
• Pediatric acute neurological symptoms may be associated with recreational drug exposure, necessitating thorough toxicological screening.
• Close monitoring for acute reversible neurological symptoms is vital in cases of suspected methamphetamine and ecstasy exposure in children.